top of page
Press Releases and News
Pluristyx and panCELLa Expand Intellectual Property Portfolio for Pluripotent Stem Cell Cloaking Technology
January 12, 2023
Pluristyx, panCELLa, and Implant Therapeutics Announce Definitive Merger Agreement
October 6, 2022
Pluristyx and Accelerated Biosciences announce availability of clinical-grade immune-privileged human trophoblast stem cells (hTSCs)
April 27, 2022
Pluristyx announces strategic alliance with panCELLa and Implant Therapeutics of offer 'off-the-shelf' induced pluripotent stem cells.
January 20, 2022
bottom of page